C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

May 31, 2009

Study Completion Date

November 30, 2009

Conditions
Cardiovascular Risk
Trial Locations (26)

Unknown

Research Site, Baja

Research Site, Békéscsaba

Research Site, Budapest

Research Site, Budapest III District

Research Site, Cegléd

Research Site, Debrecen

Research Site, Gyöngyös

Research Site, Gyula

Research Site, Jászberény

Research Site, Kalocsa

Research Site, Karcag

Research Site, Kecskemét

Research Site, Kisvárda

Research Site, Mohács

Research Site, Nyíregyháza

Research Site, Orosháza

Research Site, Pásztó

Research Site, Püspökladány

Research Site, Salgótarján

Research Site, Szarvas

Research Site, Szekszárd

Research Site, Szécsény

Research Site, Székesfehérvár

Research Site, Szolnok

Research Site, Tatabánya

Research Site, Vác

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY